Susquehanna International Group, LLP Chemo Centryx, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $959,961 - $2.24 Million	43,300 Added 24.62%	219,200 $11.3 Million
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $1.78 Million - $3.18 Million	-115,600 Reduced 39.66%	175,900 $4.36 Million
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $1.15 Million - $2.03 Million	-51,900 Reduced 15.11%	291,500 $7.31 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $2.51 Million - $5.54 Million	-136,700 Reduced 28.47%	343,400 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $1.75 Million - $2.64 Million	132,900 Added 38.28%	480,100 $8.21 Million
Q2 2021 Aug 11, 2021	BUY	$9.59 - $50.88 $3.15 Million - $16.7 Million	328,700 Added 1776.76%	347,200 $4.65 Million
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $8.83 Million - $12.2 Million	-178,300 Reduced 90.6%	18,500 $948,000
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $4.38 Million - $6.03 Million	-92,600 Reduced 32.0%	196,800 $12.2 Million
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $6.44 Million - $8.57 Million	138,900 Added 92.29%	289,400 $15.9 Million
Q2 2020 Aug 14, 2020	SELL	$38.58 - $65.07 $2.58 Million - $4.36 Million	-67,000 Reduced 30.8%	150,500 $8.66 Million
Q1 2020 May 15, 2020	SELL	$32.73 - $50.78 $972,080 - $1.51 Million	-29,700 Reduced 12.01%	217,500 $8.74 Million
Q4 2019 Feb 14, 2020	BUY	$6.81 - $39.55 $1.08 Million - $6.3 Million	159,200 Added 180.91%	247,200 $9.78 Million
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $112,578 - $155,904	17,400 Added 24.65%	88,000 $597,000
Q2 2019 Aug 14, 2019	SELL	$8.31 - $14.85 $448,740 - $801,900	-54,000 Reduced 43.34%	70,600 $657,000
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $265,265 - $368,085	26,500 Added 27.01%	124,600 $1.73 Million
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $27,450 - $36,780	-3,000 Reduced 2.97%	98,100 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$10.49 - $13.72 $871,719 - $1.14 Million	83,100 Added 461.67%	101,100 $1.28 Million
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $57,347 - $75,492	5,400 Added 42.86%	18,000 $237,000
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $74,340 - $188,874	12,600 New	12,600 $171,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.